Health And Medicine

When physician Jay Wellons was explaining to his son why the family was moving to Nashville, he put it in terms to which the 7-year-old could relate. “Daddy has a chance to join the Avengers,” he said. Read More

Thomas Wang was born in Boston, raised in Boston and educated in Boston. But Vanderbilt's emphasis on personalized medicine in both research and clinical implementation lured him to Nashville. Read More

When Todd Monroe’s grandmother was diagnosed with breast cancer late in the course of her dementia, the nursing home staff caring for her struggled to assess her pain. Read More

Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine. Read More

While the Framingham Heart Study is often referenced throughout the halls of academia, few know its origin or can fully appreciate the contribution it has made to the understanding and prevention of cardiovascular disease. Read More

Death of oligodendrocytes, the cells that make myelin, appears to be an early event in the development of multiple sclerosis. Read More

Vanderbilt researchers used existing genome-wide association study datasets to identify gene interactions that contribute to tooth decay. Read More

A panel of metabolites – small molecules that are part of metabolic processes – that are unique to macular degeneration will shed light on the disease and aid diagnosis. Read More

Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer. Read More

The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units. Read More

Jeffrey Sosman, M.D., professor of Medicine, Ingram Chair for Cancer Research and director of the Vanderbilt Melanoma Program, was named one of the Hottest Scientific Researchers of the last year by Thomas Reuters Science Watch. Read More

Recent scientific findings have raised the fear that young athletes may fare worse after sustaining a sports-related concussion than older athletes. Read More

Women with access to group prenatal care had improved birth outcomes, including longer gestational periods and higher birth weight, in a study conducted by researchers at Vanderbilt’s Peabody Research Institute. Read More

Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring. Read More

Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the “dark matter” of the genome and has begun to explore a possible new approach to treating cancer. Read More

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug. Read More

New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues. Read More

Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time. Read More

Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines. Read More

Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D. Read More